Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

miR-155 activates the NLRP3 inflammasome by regulating the MEK/ERK/NF-κB pathway in carotid atherosclerotic plaques in ApoE-/- mice.

Qing Peng | Ruihua Yin | Xiaoyan Zhu | Liying Jin | Jing Wang | Xudong Pan | Aijun Ma
Journal of physiology and biochemistry | 2022

Atherosclerosis is an inflammatory disease. The NLRP3 inflammasome and miR-155 are significant components of inflammation and atherosclerosis. The aim of this research was to explore the possible mechanism by which miR-155 mediates the formation of carotid atherosclerotic plaques via the NLRP3 inflammasome. Fifty 6-week-old male ApoE-/- mice were randomly divided into 5 groups. They are the blank group, the negative control (NC) group, the miR-155 mimic group, the miR-155 inhibitor group, and the miR-155 mimic and ERK inhibitor group. The blood lipid levels were measured by the enzyme method Oil red O, HE, and immunohistochemical staining were used to observe the degree of carotid plaque formation. PCR was used to measure the expression of miR-155. The blood lipid levels were measured by the enzyme method. Western blotting was used to measure the expression of NLRP3 inflammasome-related proteins, interleukin-1β, interleukin-18, and MEK/ERK/NF-κB signaling pathway-related proteins. Compared with those of the NC group, the expression of miR-155 in the miR-155 mimic group increased significantly (P < 0.05), the degree of carotid plaque formation increased, the plasma levels of TC and LDL also increased significantly (P < 0.05); the expression levels of NLRP3 inflammasome-related proteins, interleukin-1β, interleukin-18, and MEK/ERK/NF-κB signaling pathway-related proteins were also significantly increased. Injection of ERK inhibitors into miR-155 mimic mice reduced the expression levels of p-NF-κB, NLRP3 inflammasome-related proteins, and inflammatory cytokines. In conclusion, miR-155 can promote the formation of atherosclerotic plaque in ApoE-/- mice, which may be achieved by regulating the MEK/ERK/NF-κB pathway to activate the NLRP3 inflammasome. HIGHLIGHTS: • In ApoE-/- mice, miR-155 promotes atherosclerotic plaque formation. • The NLRP3 inflammasome has an important role in the inflammatory process of atherosclerosis. • miR-155 activates the NLRP3 inflammasome by regulating the MEK/ERK/NF-κB pathway in carotid atherosclerotic plaques of ApoE-/- mice.

Pubmed ID: 35079982

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


caspase-1 (14F468) (antibody)

RRID:AB_781816

This monoclonal targets caspase-1 (14F468)

View all literature mentions

NLRP3 (D4D8T) (antibody)

RRID:AB_2722591

This monoclonal targets NLRP3

View all literature mentions

Anti -F4/80 (antibody)

RRID:AB_2814687

This polyclonal targets F4/80

View all literature mentions

Anti-IL-1 beta antibody (antibody)

RRID:AB_308765

This polyclonal targets IL1 beta

View all literature mentions

MEK1/2 Antibody (antibody)

RRID:AB_823567

This polyclonal targets MEK1/2

View all literature mentions

Anti-GABA-A-R-Beta2/3 Antibody (antibody)

RRID:AB_2315838

This monoclonal targets GABA-A-R-Beta2/3

View all literature mentions

p44/42 MAPK (Erk1/2) (137F5) Rabbit mAb (antibody)

RRID:AB_390779

This monoclonal targets p44/42 MAPK (Erk1/2)

View all literature mentions